Zifcasiran
Zifcasiran (ADS-007; ARO HIF2) is an siRNA synthetic double-stranded RNAi trigger. Zifcasiran sodium selectively target hypoxia-inducible factor-2α (HIF2α) interrupting downstream pro-oncogenic signaling in clear cell renal cell carcinoma (ccRCC). Zifcasiran sodium engages the cell's RNAi machinery to target HIF2α (EPAS1) mRNA for degradation, thereby reducing the amount of free HIF2α mRNA available for translation.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 2437257-11-7
- 화학식: C737H972F20N211O349P43S8
- 분자량:20339.13
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 2437257-11-7
-
분자량 20339.13
-
화학식 C737H972F20N211O349P43S8
-
SMILES
[Zifcasiran]
-
Synonyms
ADS-007; ARO HIF2
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
- Zifcasiran
- 2437257-11-7
- ADS-007
- ARO HIF2
- ADS007
- ADS 007
- ARO HIF2
- ARO HIF 2
- ARO HIF-2
- Small Interfering RNA (siRNA)
- HIF/HIF Prolyl-Hydroxylase
- RNAi machinery
- HIF2α
- ccRCC tumorgrafts
- clear cell renal cell carcinoma
- HIF2α mRNA
- αvβ3 integrin ligand
- erythropoietin
- HIF1α mRNA
- nude mice
- HIF2α protein
- Inhibitor
- inhibitor
- inhibit